319
Views
12
CrossRef citations to date
0
Altmetric
Biochemistry & Molecular Biology

Downregulation of RPS15A by miR-29a-3p attenuates cell proliferation in colorectal carcinoma

, , &
Pages 2057-2064 | Received 09 Apr 2019, Accepted 31 May 2019, Published online: 13 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Song Qi, Li Xu, Yongyuan Han, Hongkun Chen & Anyuan Cheng. (2022) miR-29a-3p mitigates the development of osteosarcoma through modulating IGF1 mediated PI3k/Akt/FOXO3 pathway by activating autophagy. Cell Cycle 21:18, pages 1980-1995.
Read now

Articles from other publishers (11)

Tao Liu, Detao Ding, Wei Wang, Yungang Wu, Dengdian Ma, Miaomiao Liu, Ziqiao Tan, Jing Yao & Xiaoyu Li. (2023) The role and clinical significance of microRNA-29a-3p in the development of hypopharyngeal carcinoma. Brazilian Journal of Otorhinolaryngology 89:3, pages 401-409.
Crossref
Wen-Yan Mo & Shi-Qiong Cao. (2022) MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer. Clinical and Translational Oncology 25:3, pages 563-577.
Crossref
Qiaolin Xu, Xiaoxue Lu, Jing Li, Yuyang Feng, Jie Tang, Tao Zhang, Yilan Mao, Yuanzhi Lan, Huaxing Luo, Linghai Zeng, Yuanyuan Xiang, Lv Hu, Yan Zhang, Qian Li, Ling Deng, Xiaoyi He, Bin Tang, Xuhu Mao & Dongzhu Zeng. (2022) Fusobacterium nucleatum induces excess methyltransferase‐like 3‐mediated microRNA‐4717‐3p maturation to promote colorectal cancer cell proliferation . Cancer Science 113:11, pages 3787-3800.
Crossref
Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Peixin Dong, Nikolaus Gassler, Mohammad Taheri, Aria Baniahmad & Nader Akbari Dilmaghani. (2022) A review on the role of cyclin dependent kinases in cancers. Cancer Cell International 22:1.
Crossref
Kang Zhang, Xiaoliang Han, Wenbin Hu, Chao Su & Binjun He. (2022) miR‑29a‑3p inhibits the malignant characteristics of non‑small cell lung cancer cells by reducing the activity of the Wnt/β‑catenin signaling pathway. Oncology Letters 24:4.
Crossref
Dasom Hwang, Dahye Kim, Yunhee Chang, Workneh Korma Hirgo & Hyeyoung Lee. (2021) Expression of miR-29a in whole Blood of Patients with Colorectal Neoplasm. Biomedical Science Letters 27:4, pages 216-222.
Crossref
Aizhi Geng, Lin Luo, Fengyun Ren, Ling Zhang, Haiying Zhou & Xue Gao. (2021) miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1. BMC Cancer 21:1.
Crossref
Sai Liu, Dongjuan Liu, Jinwen Liu, Jiayi Liu & Ming Zhong. (2021) miR ‐29a‐3p promotes migration and invasion in ameloblastoma via Wnt/β‐catenin signaling by targeting catenin beta interacting protein 1 . Head & Neck 43:12, pages 3911-3921.
Crossref
Wei Huang, Faling Xiao, Weijun Huang, Qiaosong Wei & Xisong Li. (2021) MicroRNA-29a-3p strengthens the effect of dexmedetomidine on improving neurologic damage in newborn rats with hypoxic-ischemic brain damage by inhibiting HDAC4. Brain Research Bulletin 167, pages 71-79.
Crossref
Weifu Zhou, Hui Li, Shuo Shang & Feng Liu. (2021) lncRNA KCNQ1OT1 reverses the effect of sevoflurane on hepatocellular carcinoma progression via regulating the miR-29a-3p/CBX3 axis. Brazilian Journal of Medical and Biological Research 54:7.
Crossref
Qian Ning, Yamei Pang, Shan Shao, Minna Luo, Lin Zhao, Tinghua Hu & Xinhan Zhao. (2019) MicroRNA‐147b suppresses the proliferation and invasion of non‐small‐cell lung cancer cells through downregulation of Wnt/β‐catenin signalling via targeting of RPS15A. Clinical and Experimental Pharmacology and Physiology 47:3, pages 449-458.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.